With the analysis among 71 patents, we discovered top 17 key players by total patent application. Boehringer Ingelheim International GmbH, Innovent Biologics (Suzhou) Co. Ltd., Nanjing IASO Biotherapeutics Co., Ltd. are dominant in this area. They take 66.20% of the total patent filing.
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 20
Innovent Biologics (Suzhou) Co. Ltd.
Jiangsu Sheng, China
Patent: 15
Nanjing IASO Biotherapeutics Co., Ltd.
Jiangsu Sheng, China
Patent: 12
Washington, United States
Patent: 9
Gyeonggi-do, South Korea
Patent: 8
Hangzhou Sumgen Biotech Co., Ltd.
Zhejiang Sheng, China
Patent: 4
Sumgen Monoclonal Antibody (Beijing) Biotechnology Co Ltd
Beijing Shi, China
Patent: 4
Shanghai Shi, China
Patent: 3
Yuandaolong (Suzhou) Medical Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 2
Autobio Diagnostics Co., Ltd.
Henan Sheng, China
Patent: 1
With the analysis among 16 patents, we discovered top 2 start-ups by total patent application.
Nanjing IASO Biotherapeutics Co., Ltd.
Jiangsu Sheng, China
Patent: 12
Hangzhou Sumgen Biotech Co., Ltd.
Zhejiang Sheng, China
Patent: 4
With the analysis among related 50 patents applied in the last 5 years. We discover 21 most active companies in this area. The fast-growing Innovent Biologics (Suzhou) Co. Ltd., Nanjing IASO Biotherapeutics Co., Ltd., ABL Bio, Inc. take 70.00% of patent filing during this period.
Innovent Biologics (Suzhou) Co. Ltd.
Jiangsu Sheng, China
Patent: 15
Nanjing IASO Biotherapeutics Co., Ltd.
Jiangsu Sheng, China
Patent: 12
Gyeonggi-do, South Korea
Patent: 8
Hangzhou Sumgen Biotech Co., Ltd.
Zhejiang Sheng, China
Patent: 4
Sumgen Monoclonal Antibody (Beijing) Biotechnology Co Ltd
Beijing Shi, China
Patent: 4
Julius-Maximilians-Universität Würzburg
Shanghai Shi, China
Patent: 3
Yuandaolong (Suzhou) Medical Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 2
Washington, United States
Patent: 2
Washington, United States
Patent: 2
With the analysis among related 50 patents in last 5 years, we discover 19 new entrants. Innovent Biologics (Suzhou) Co. Ltd., Nanjing IASO Biotherapeutics Co., Ltd., ABL Bio, Inc. are the most active new entrants in this area.
Innovent Biologics (Suzhou) Co. Ltd.
Jiangsu Sheng, China
Patent: 15
Nanjing IASO Biotherapeutics Co., Ltd.
Jiangsu Sheng, China
Patent: 12
Gyeonggi-do, South Korea
Patent: 8
Hangzhou Sumgen Biotech Co., Ltd.
Zhejiang Sheng, China
Patent: 4
Sumgen Monoclonal Antibody (Beijing) Biotechnology Co Ltd
Beijing Shi, China
Patent: 4
Julius-Maximilians-Universität Würzburg
Shanghai Shi, China
Patent: 3
Yuandaolong (Suzhou) Medical Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 2
Nanjing Inhans Biotechnology Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Autobio Diagnostics Co., Ltd.
Henan Sheng, China
Patent: 1
With the analysis among 16 patents, we discovered top 3 universities and scientific research institutions by total patent application.
Washington, United States
Patent: 9
Julius-Maximilians-Universität Würzburg
East China Normal University
Shanghai Shi, China
Patent: 1